id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-348846-mfhxac5c	Coletto, Lavinia Agra	Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID‐19 days	2020-05-02		.txt	text/plain	299	12	19	Rheumatology (Oxford) Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK populationbased cohort study. In conclusion, before interrupting a chronic therapy, even if patients with PsA have an increased risk of comorbidities and serious infections compared with patients with psoriasis, 7 we suggest evaluating not only the infectious profile of immunosuppressants but also the underlying inflammatory nature of psoriatic disease itself, especially if severe and/or associated with articular involvement. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants?	cache/cord-348846-mfhxac5c.txt	txt/cord-348846-mfhxac5c.txt
